Prevalence of Pre‐Clinical Obesity Among US Adults Receiving Medical and Surgical Obesity Treatment
Authors' conclusion
This novel framework would reclassify a significant proportion of patients as having pre-clinical obesity.
Study context
- Population
- US adults with BMI ≥ 35 who received bariatric surgery (BS) or antiobesity medications (AOMs), 2017–2023, ≥ 6-month continuous enrollment before treatment
- Exposure
- Clinical obesity vs pre-clinical obesity
- Outcome
- Proportion classified as pre-clinical vs clinical obesity
Methodological detailsMerative MarketScan database, multivariable logistic regression
- Merative MarketScan database
- Multivariable logistic regression
Main finding
As reported in the abstract
Prevalence of pre-clinical obesity
Observational data: associations, not effects.
Further findings
Characteristics
- Clinical obesity patients were older with a higher comorbidity burden vs pre-clinical obesity
Safety
| Outcome | aOR | P value |
|---|---|---|
| Treatment-related complications · within 90 days of treatment initiationClinical obesity vs Pre-clinical obesity · AOM | 1.10 | P < 0.001 |
| Treatment-related complications · within 90 days of treatment initiationClinical obesity vs Pre-clinical obesity · BS | 1.39 | P < 0.001 |
Original publication
Prevalence of Pre‐Clinical Obesity Among US Adults Receiving Medical and Surgical Obesity Treatment. Obesity (Silver Spring). Published 20 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →